4th Quarter - Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA approval and enforcement issues.

Foreign entity interest: 100% ownership by Roche Holding, Ltd., 4070 Basel, Switzerland.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.